Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthrometry, Articular | 1 | 2018 | 2 | 0.580 |
Why?
|
| Wrist Joint | 1 | 2018 | 25 | 0.570 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 103 | 0.550 |
Why?
|
| Smartphone | 1 | 2018 | 71 | 0.530 |
Why?
|
| Mobile Applications | 1 | 2018 | 140 | 0.490 |
Why?
|
| Osteolysis | 1 | 2010 | 18 | 0.330 |
Why?
|
| Boronic Acids | 1 | 2010 | 28 | 0.330 |
Why?
|
| Pyrazines | 1 | 2010 | 35 | 0.330 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 106 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 532 | 0.270 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1213 | 0.180 |
Why?
|
| Pronation | 1 | 2018 | 4 | 0.140 |
Why?
|
| Supination | 1 | 2018 | 6 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 75 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2010 | 320 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 685 | 0.110 |
Why?
|
| Calcitriol | 2 | 2005 | 25 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 129 | 0.110 |
Why?
|
| Osteoblasts | 3 | 2011 | 198 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 115 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2015 | 124 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2605 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 350 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1622 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2621 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 36 | 0.080 |
Why?
|
| Bortezomib | 1 | 2010 | 56 | 0.080 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 142 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2011 | 143 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 101 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 195 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 210 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 192 | 0.080 |
Why?
|
| Mice, SCID | 1 | 2010 | 517 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 220 | 0.080 |
Why?
|
| Stem Cells | 1 | 2011 | 262 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 4782 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2005 | 140 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1494 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 667 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2005 | 74 | 0.060 |
Why?
|
| Female | 3 | 2018 | 33383 | 0.060 |
Why?
|
| Phosphates | 1 | 2005 | 93 | 0.060 |
Why?
|
| Adenine | 1 | 2004 | 50 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 191 | 0.050 |
Why?
|
| Mice | 4 | 2011 | 10994 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 674 | 0.050 |
Why?
|
| Male | 4 | 2018 | 30322 | 0.050 |
Why?
|
| Aged | 1 | 2018 | 14663 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 17136 | 0.040 |
Why?
|
| Middle Aged | 1 | 2018 | 17923 | 0.040 |
Why?
|
| Humans | 3 | 2018 | 64272 | 0.040 |
Why?
|
| Animals | 4 | 2011 | 20955 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 760 | 0.040 |
Why?
|
| Pathology, Surgical | 1 | 2015 | 12 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 61 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 197 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 519 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 577 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2011 | 7 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1020 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2011 | 20 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 2011 | 14 | 0.020 |
Why?
|
| Rats | 2 | 2005 | 2005 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 2057 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1297 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 3449 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2005 | 11 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2005 | 22 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 80 | 0.010 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2004 | 55 | 0.010 |
Why?
|
| Poly A | 1 | 2004 | 29 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 57 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.010 |
Why?
|
| Sarcoma | 1 | 2004 | 36 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 60 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 375 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 261 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 417 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 544 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 614 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 312 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 455 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 696 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 914 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 1335 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1999 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 634 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 884 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 844 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1552 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 3725 | 0.010 |
Why?
|